Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

VBIV

VBI Vaccines (VBIV)

VBI Vaccines Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VBIV
DateTimeSourceHeadlineSymbolCompany
12:52PMiHub NewswireFeaturedCannabix Technologies Begins Certification of Contactless Alcohol Breathalyzer, Re-Brands product series to Breath Logix
04/16/20248:00AMBusiness WireVBI Vaccines Reports Full Year 2023 Financial ResultsNASDAQ:VBIVVBI Vaccines Inc
04/11/20244:05PMBusiness WireVBI Vaccines Announces Closing of $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:VBIVVBI Vaccines Inc
04/09/20242:45PMBusiness WireVBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:VBIVVBI Vaccines Inc
04/03/20248:00AMBusiness WireVBI Vaccines Presents Encouraging Early Tumor Response Data From Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent GlioblastomaNASDAQ:VBIVVBI Vaccines Inc
04/02/20248:00AMBusiness WireVBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine PlatformNASDAQ:VBIVVBI Vaccines Inc
02/14/20248:34AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
02/14/20247:00AMBusiness WireVBI Announces Agreement to Sell Manufacturing Capabilities, Certain Related Assets, and Enter Into New License Agreement with Brii BiosciencesNASDAQ:VBIVVBI Vaccines Inc
02/06/20244:23PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
01/23/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
01/11/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
12/26/20234:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
12/12/20234:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
11/29/20234:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
11/20/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
11/20/20238:00AMBusiness WireVBI Vaccines Presents Additional Biomarker Data from Phase 1/2a Study of VBI-1901 in Recurrent GBM at the 2023 Society for Neuro-Oncology (SNO) Annual MeetingNASDAQ:VBIVVBI Vaccines Inc
11/14/20234:07PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
11/14/20234:06PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VBIVVBI Vaccines Inc
11/14/20234:05PMBusiness WireVBI Vaccines Reports Third Quarter 2023 Financial ResultsNASDAQ:VBIVVBI Vaccines Inc
11/03/20235:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
10/26/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
10/26/20238:00AMBusiness WireVBI Vaccines Expands Proprietary Technology Platforms With Development of a Novel mRNA-Launched eVLP Vaccine ProgramNASDAQ:VBIVVBI Vaccines Inc
09/27/20237:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
09/27/20237:30AMBusiness WireVBI Vaccines’ Pan-Coronavirus Vaccine Candidate, VBI-2901, Induced Broad and Durable Protective Titers Against Variants of ConcernNASDAQ:VBIVVBI Vaccines Inc
09/07/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
09/07/20238:00AMBusiness WireVBI Vaccines Announces Dosing of First Patients in Phase 2b Study of VBI-1901 in Recurrent GBMNASDAQ:VBIVVBI Vaccines Inc
09/06/20239:12AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
09/06/20238:00AMBusiness WireVBI Vaccines Partner Brii Biosciences Announces Topline Interim Results of Phase 2 Study Evaluating BRII-179 (VBI-2601) in Combination With PEG-IFNα for the Treatment of Chronic Hepatitis BNASDAQ:VBIVVBI Vaccines Inc
08/14/20238:00AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VBIVVBI Vaccines Inc
08/14/20238:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:VBIVVBI Vaccines Inc
 Showing the most relevant articles for your search:NASDAQ:VBIV